BALPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > balpharma

Technical Analysis

Technical Strength: 1.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 36.2. According to RSI analysis, balpharma is technically weak. 1.0 BALPHARMA RSI Chart
MACD (?) MACD: -2.29 and Signal Line: -2.23. According to MACD analysis, balpharma is technically weak. 2.0 BALPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, balpharma is in a downtrend. Resistance level is at 93.1. 1.0 BALPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, balpharma is in a strong downtrend. Major resistance levels are 92.85838, 96.38938, 97.63894. 0.0 BALPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.128. According to bollinger bands, balpharma is technically weak. 3.0 BALPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 97.0076 and 101.35. Support level is 82.95. 2.5 BALPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 3.52 NA BALPHARMA Average True Range Chart
Average Directional Index (?) ADX is 19.1 which means BALPHARMA is in a trading range and there is no trend. NA BALPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 16, 2018
Open Price 91.15
High Price 91.5
Low Price 89.1
Close Price 89.6
Absolute Change -0.55
Percentage Change -0.61%
Weekly Change -1.81%
Monthly Change -4.27%
Yearly Change -1.21%
52-week high 128.2
52-week low 82.95
Corporate Actions
ExDate Purpose
September 14, 2017 AGM/DIV-RE 1 PER SHARE
September 15, 2016 AGM/DIV RE 1/- PER SHARE
September 12, 2013 AGM/DIV-RE 0.75 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.745
Confidence in Beta2.41%
Market Capital Rs. 115.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 3.11
TTM Price-to-Earnings (P/E) Ratio 28.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 16 March 2018: Deliverable Quantity:9.66e+03 NA BALPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 March 2018: Daily Volatility:0.426 NA BALPHARMA Annualized Daily Volatility (Spot Price) Chart


March 07, 2018 BPress ReleaseBal Pharma Limited has informed the Exchange regarding a press release dated March 06, 2018, titled "
February 15, 2018 BOutcome of Board MeetingBal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2018.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 29, 2018 February 14, 2018 TResultsThe Board of Directors inter alia will be considering approval of un audited stand alone and consolidated financial results of the Company for the quarter ended December 31, 2017.
November 15, 2017 December 11, 2017 IResultsInter alia will be considering approval of un audited stand alone and consolidated financial results of the Company for the quarter and half year ended September 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 86.23 Rs. 87.67 Rs. 88.63 Rs. 90.07 Rs. 91.03 Rs. 92.47 Rs. 93.43